XML 16 R40.htm IDEA: XBRL DOCUMENT v3.19.3
Agreements - Takeda (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2018
USD ($)
Mar. 31, 2015
item
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2019
USD ($)
item
Sep. 30, 2018
USD ($)
Collaborative Agreements disclosures            
Revenue from contract with customer     $ 13,281 $ 10,928 $ 37,407 $ 40,030
Takeda            
Collaborative Agreements disclosures            
Term of agreement   3 years        
Number of single-target licenses | item   2     1  
Revenue from contract with customer           $ 10,900
Type of Revenue           imgn:LicenseAndMilestoneFeesMember
Takeda | Phase 1 clinical trial            
Collaborative Agreements disclosures            
Revenue from contract with customer $ 5,000          
Takeda | Phase 2 clinical trial            
Collaborative Agreements disclosures            
Revenue from contract with customer $ 10,000          
License and milestone fees            
Collaborative Agreements disclosures            
Revenue from contract with customer     $ 79 $ 672 $ 5,237 $ 13,533